Influence of Fibrinogen and Hematocrit on the Early Outcome of Angioplasty in Patients with PAOD

Journal of Endovascular Therapy

Volumn 11, Issue 2, 2004, Pages 125-131

  Rudofsky, Gottfried ^a,b   Strubel, Gerson ^a   Michler, Eveline ^a   Kuegler, Christian ^a   Biro, Ferenc ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Angioplasty; Blood viscosity; Diabetes; Fibrinogen; Hematocrit; Outcome analysis; Peripheral arterial occlusive disease

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMATOCRIT; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; DIABETIC ANGIOPATHIES; FEMALE; FIBRINOGEN; HEMATOCRIT; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; TREATMENT OUTCOME;

EID: 1842782832     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/01-651R.1     Document Type: Article

References (29)

1. Heinrich J, Schulte H, Schonfeld R, et al. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 1995;73:374-379.
2. Kannel WB, Wilson PW. Comparison of risk profiles for cardiovascular events: implications for prevention. Adv Intern Med. 1997;42:39-66.
3. Kannel WB. Influence of fibrinogen on cardiovascular disease. Drugs. 1997;54(suppl. 3):32-40.
4. Mazoyer E, Drouet L, Soria C, et al. Risk factors and outcomes for atherothrombotic disease in French patients: the Rivage Study. Risque Vasculaire Group d'Etude. Thromb Res. 1999;95:163-176.
5. Scarabin PY, Aillaud MF, Amouyel P, et al. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction - the PRIME Study. Thromb Haemost. 1998;80:749-756.
6. Peters AJ, Schoebel FC, Jax TW, et al. Long-term urokinase therapy and isovolemic hemodilution: a clinical and hemodynamic comparison in patients with refractory angina pectoris. Int J Angiol. 1999;8:44-49.
7. Bikfalvi A. Fibrin/fibrinogen. In: Bikfalvi A, ed. Vascular Biology and Pathology. New York: Springer Verlag; 2000:107-122 and 125-141.
8. Dormandy JA, Hoare E, Khattab AH, et al. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Brit Med J. 1973;4:581-583.
9. Dormandy JA, Yates CJ, Berent GA. Clinical relevance of blood viscosity and red cell deformability including new therapeutic aspects. Angiology. 1981;32:236-242.
10. Rieger H, Leye A, Schmidt-Schonbein H, et al. Isovolaemische Haemodilution bei peripherer arterieller Verschlusskrankheit. Konzepte, Methoden and vorlaufige Ergebnisse. In: Alexander KM, ed. Diabetische Angiopathien, New York: G. Witzstrock Verlag; 1977:354.
11. Rudofsky G, Meyer P. Die Hamatokritabhangigkeit der arteriellen Durchblutung in kritischen Kreislaufsituationen. In: Trubestein G, ed. Konservative Therapie arterieller Durchblutungsstorungen. Stuttgart: Thieme Verlag; 1986:277-281.
12. Ceriello A. Fibrinogen and diabetes mellitus: is it time for intervention trials? Diabetologia. 1997;40:731-734.
13. Morale M, De Negri F, Carmassi F. Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis. Diabetologia. 1997;40:735-737.
14. Smith SC, Greenland P, Grundy SM. Prevention conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. American Heart Association. Circulation. 2000;101:111-116.
15. Linderkamp O, Ruef P, Zilow EP, et al. Impaired deformability of erythrocytes and neutrophils in children with newly diagnosed insulin-dependent diabetes mellitus. Diabetologia. 1999;42:865-869.
16. Conroy RM, Gordon IL, Tobis JM, et al. Angioplasty and stent placement in chronic occlusion of the superficial femoral artery: technique and results. J Vasc Interv Radiol. 2000;11:1009-1020.
17. Danielsson G, Albrechtsson U, Norgren L, et al. Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing success. Eur Vasc Endovasc Surg. 2001;21:432-436.
18. Hintner M, Behrmann C. Long-term results of angioplasties of pelvic and leg blood vessels [in German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2000;172:775-779.
19. Matsi PJ, Manninen HI. Complications of lower-limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Intervent RadioL 1998;21:361-366.
20. Nicholson T. Percutaneous transluminal angioplasty and enclosed thrombolysis versus percutaneous transluminal angioplasty in the treatment of femoropopliteal occlusions: results of a prospective randomized trial. Cardiovasc Intervent Radiol. 1998;21:470-474.
21. Rutherford RB, Flanigan DP, Gupta SK, et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg. 1986;4:80-94.
22. Melliere D, Berrahal D, Daudiffret A, et al. Percutaneous transluminal angioplasty in patients with ischemic tissue necrosis is worthwhile. Cardiovasc Surg. 2001;9:122-126.
23. Sandmann W, Kniemeyer HW, Jalschak R, et al. Surgical treatment of peripheral arterial occlusive disease in diabetes mellitus; in situ saphenous vein bypass versus reverse bypass procedure - a retrospective study [in German]. Vasa. 1990;19:47-53.
24. Feinstein AR. Clinical biostatistics. X. Sources of 'transition bias' in cohort statistics. Clin Pharmacol Ther. 1971;12:704-721.
25. Bollinger A. Funktionelle Angiologie. Stuttgart: Thieme Verlag; 1979:57-84.
26. Ahn SS, Rutherford RB, Becker GJ, et al. Reporting standards for lower extremity arterial endovascular procedures. J Vasc Surg. 1993;17:1103-1107.
27. Killewich LA, Gardner AW, Macko RF, et al. Progressive intermittent claudication is associated with impaired fibrinolysis. J Vasc Surg. 1998;27:645-650.
28. Mahir MS, Hynd JW, Flute PT, et al. The effect of normovolaemic haemodilution on the early patency rate of small calibre vascular prostheses studied in a new animal model. Thromb Res. 1986;41:771-780.
29. Mahir MS, Hynd JW, Flute PT, et al. Effect of defibrinogenation on the early patency rate of experimental small calibre arterial grafts. Br J Surg. 1987;74:508-510.